Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche’s Herceptin successor impresses at EMCC

September 27, 2011
Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …

News
Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011
Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …

News

MTS Medication Technologies appoints Paul O’Hanlon

September 27, 2011
Manufacturing and Production appointments, manufacturing and production

MTS Medication Technologies has appointed Paul O’Hanlon as managing director of its International Division. He has 27 years of experience …

Appointment

Lonza signs regenerative medicine deal with Mesoblast

September 27, 2011
Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news

Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …

News

SCM Pharma unveils formulation development business

September 27, 2011
Manufacturing and Production SCM Pharma, phamra manufacturing news, pharma manufacturing news

UK contract manufacturer SCM Pharma has set up a formulation development business, thanks to a collaboration with the University of …

News

Pharma manufacturing news in brief

September 26, 2011
Manufacturing and Production pharma manufacturing news

This week’s roundup includes contract manufacturing updates from CMC Biologics, West-Ward and Aenova, plus a Catalent deal in Japan and …

News

Bridgehead International appoints Marcus Deans

September 26, 2011
Sales and Marketing appointment, sales and marketing

London-based consultants Bridgehead International have appointed Marcus Deans as principal consultant. He joins the firm, which specialises in market access, …

Appointment

Xarelto poised for two new chronic indications

September 26, 2011
Sales and Marketing Xarelto

Bayer HealthCare’s oral bloodthinner Xarelto has been recommended for approval in Europe for two new chronic indications. The Committee for …

News

Roche’s Avastin set for new ovarian cancer indication in Europe

September 26, 2011
Sales and Marketing avastin, ovarian cancer

Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …

News
Sanofi's Multaq

Safety concerns prompt Multaq restrictions

September 26, 2011
Sales and Marketing Multaq

The European Medicines Agency has recommended Sanofi’s Multaq be restricted due to ongoing concerns about its safety profile. The drug …

News
Roche's Avastin

Avastin faces greater scrutiny over eye disease use

September 23, 2011
Sales and Marketing avastin, macular oedema

The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …

News

Carolin Prasmo returns to Aurora

September 23, 2011
Medical Communications appointment, medical communications

Farringdon, UK-based comms agency Aurora has appointed Carolin Prasmo as senior account account manager. She was originally one of the …

Appointment
virgo_health_education_jenny_szkolar

Virgo Health Education expands scientific and client service teams

September 23, 2011
Medical Communications appointment, medical communications

Virgo has expanded its Health Education business unit with the appointments of Jenny Szkolar and Vicky Cadman. Jenny (pictured) joins …

Appointment

Boehringer censured over Pradaxa marketing

September 23, 2011
Medical Communications ABPI Code of Practice, Boehringer

Boehringer Ingelheim has been heavily censured by the body which enforces the ABPI’s Code of Practice for the content of …

News

Roche cleared over rep conduct complaint

September 23, 2011
Sales and Marketing ABPI Code of Practice, Roche

Roche has been cleared by Code regulator the PMCPA of any wrongdoing after an NHS employee complained about the promotion …

News

Value-based pricing won’t encourage innovation, says ABPI

September 23, 2011
Sales and Marketing value-based pricing

The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …

News

NHS ‘wasted’ £625 million on modern insulin

September 23, 2011
Sales and Marketing diabetes, insulin

The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …

News

Healthcare 2025: what the future holds for pharma

September 22, 2011
Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …

Feature

J&J’s hep C drug Incivo approved in Europe

September 22, 2011
Sales and Marketing Incivek, Incivo, Victrelis

J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …

News

Sanofi spots acne vaccine opportunity

September 22, 2011
Research and Development Sanofi, acne, dermatology

Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …

News
The Gateway to Local Adoption Series

Latest content

PSI announces new Osaka office as part of Japanese expansion

January 12, 2026

Teva’s Ajovy significantly reduces migraine in children and adolescents

January 12, 2026

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026